Biotech Values

[io_io]

CRME:

I remember looking at the phase III results approx 6 months ago, and listened to a CC, and I was impressed. It looks like their lead drug has clear efficacy, and FDA approval seemed likely once its filed. On the other hand, they had already sold the USA rights. I decided to pass, not knowing either the milestone/royalty terms, and not having time to learn anything about that medical area. But it looked cheap then, and cheaper now.